GHRS Company Profile and Key Details

Q: Who are the executives of GHRS?

Ms. Julie Ryan F.C.A.Vice President of Fin.Dr. Theis Terwey M.D.Co-Founder & Chief Executive OfficerMr. Aaron CameronVice President of Technical Devel. & Operational PlanningMr. Theis Terwey M.D.Co-Founder & Chief Executive OfficerMs. Julie Ryan A.C.A.Vice President of Fin.Mr. Florian Schonharting M.Sc. (Econ)Co-Founder & Non-Executive ChairmanMr. Magnus HalleCo-Founder & MD of Ireland

NASDAQ : GHRS

GH Research

$27.28

-0.28-1.02%

At Close 4:00 PM

58.75

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

GH Research PLC (GHRS) stock declined over -1.02%, trading at $27.28 on NASDAQ, down from the previous close of $27.56. The stock opened at $27.24, fluctuating between $26.88 and $27.61 in the recent session.

Stock Snapshot

27.56

Prev. Close

1.87B

Market Cap

26.875

Day Low

-27.28

P/E Ratio

-1

EPS (TTM)

-0.64

Cash Flow per Share

27.24

Open

68.56M

Number of Shares

27.605

Day High

67.61%

Free Float in %

4.21

Book Value

128.8K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	27.24	27.61	26.88	27.28	128.8K
Sep 09, 2026	27.77	27.92	26.46	27.56	336.79K
Sep 08, 2026	27.98	28.33	27.21	27.79	221.03K
Sep 04, 2026	27.86	28.31	27.26	28.23	78.1K
Sep 03, 2026	28.19	28.33	27.58	27.92	116.96K
Sep 02, 2026	27.46	28.32	27.09	28.07	111.85K
Sep 01, 2026	26.94	28.00	26.61	27.36	464.91K
Aug 31, 2026	27.86	28.07	26.68	26.98	149.5K
Aug 28, 2026	28.61	28.61	27.82	27.94	117.63K
Aug 27, 2026	29.02	29.08	28.44	28.65	73.51K
Aug 26, 2026	28.92	29.14	28.38	29.01	145.07K
Aug 25, 2026	28.46	29.13	28.46	28.92	113.12K
Aug 24, 2026	28.20	28.60	27.24	28.10	162.75K
Aug 21, 2026	28.83	29.22	28.01	28.33	141.7K
Aug 20, 2026	29.74	29.89	28.55	28.68	172.27K
Aug 19, 2026	29.90	30.57	29.38	29.80	357.33K
Aug 18, 2026	30.00	30.26	29.05	29.74	238.66K
Aug 17, 2026	29.26	30.07	29.15	29.98	182.23K
Aug 14, 2026	28.31	30.19	28.25	29.49	233.47K
Aug 13, 2026	30.31	30.31	28.05	28.19	351.55K

Contact Details

Dublin, DU D02 RY95

Ireland

https://www.ghres.com 353 143 78443

About Company

GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.

Stock Peers

ARGX

-18.27-1.82%

argenx SE$984.04 REGN

-14.39-1.78%

Regeneron Pharmaceuticals, Inc.$793.26 MDGL

-13.54-2.48%

Madrigal Pharmaceuticals, Inc.$533.12 VRTX

-6.56-1.26%

Vertex Pharmaceuticals Incorporated$514.56 UTHR

-2.96-0.58%

United Therapeutics Corporation$503.86 KRYS

-2.54-0.73%

Krystal Biotech, Inc.$345.55 ONC

-9.2-2.62%

BeOne Medicines AG$341.80 PRAX

-6.73-1.95%

Praxis Precision Medicines, Inc.$338.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

1.2+0.42%

Ligand Pharmaceuticals Incorporated$289.25

Frequently Asked Questions

What is the current GH Research PLC (GHRS) stock price?

GH Research PLC (NASDAQ: GHRS) stock price is $27.28 in the last trading session. During the trading session, GHRS stock reached the peak price of $27.61 while $26.88 was the lowest point it dropped to. The percentage change in GHRS stock occurred in the recent session was -1.02% while the dollar amount for the price change in GHRS stock was - $0.28.

GHRS's industry and sector of operation?

The NASDAQ listed GHRS is part of Biotechnology industry that operates in the broader Healthcare sector. GH Research PLC designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GHRS?

Ms. Julie Ryan F.C.A.
Vice President of Fin.
Dr. Theis Terwey M.D.
Co-Founder & Chief Executive Officer
Mr. Aaron Cameron
Vice President of Technical Devel. & Operational Planning
Mr. Theis Terwey M.D.
Co-Founder & Chief Executive Officer
Ms. Julie Ryan A.C.A.
Vice President of Fin.
Mr. Florian Schonharting M.Sc. (Econ)
Co-Founder & Non-Executive Chairman
Mr. Magnus Halle
Co-Founder & MD of Ireland

How GHRS did perform over past 52-week?

GHRS's closing price is 130.6% higher than its 52-week low of $11.83 where as its distance from 52-week high of $31.44 is -13.23%.

How many employees does GHRS have?

Number of GHRS employees currently stands at 73.

Link for GHRS official website?

Official Website of GHRS is: https://www.ghres.com

How do I contact GHRS?

GHRS could be contacted at phone 353 143 78443 and can also be accessed through its website. GHRS operates from Joshua Dawson House, Dublin, DU D02 RY95, Ireland.

How many shares of GHRS are traded daily?

GHRS stock volume for the day was 128.8K shares. The average number of GHRS shares traded daily for last 3 months was 280.03K.

What is the market cap of GHRS currently?

The market value of GHRS currently stands at $1.87B with its latest stock price at $27.28 and 68.56M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	73
Beta	1.29
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	73
Beta	1.29
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

GHRS Company Profile and Key Details

GH Research

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook